These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 3020747)
1. CMV infection, class II antigen expression, and human kidney allograft rejection. von Willebrand E; Pettersson E; Ahonen J; Häyry P Transplantation; 1986 Oct; 42(4):364-7. PubMed ID: 3020747 [TBL] [Abstract][Full Text] [Related]
2. The influence of the pattern of inflammation and administration of steroids on class II MHC antigen expression in renal transplants. Häyry P; von Willebrand E Transplantation; 1986 Oct; 42(4):358-63. PubMed ID: 3094208 [TBL] [Abstract][Full Text] [Related]
3. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function. Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982 [TBL] [Abstract][Full Text] [Related]
4. Enhancement of cytomegalovirus infection and acute rejection after allogeneic lung transplantation in the rat: virus-induced expression of major histocompatibility complex class II antigens. You XM; Steinmüller C; Wagner TO; Bruggeman CA; Haverich A; Steinhoff G J Heart Lung Transplant; 1996 Nov; 15(11):1108-19. PubMed ID: 8956120 [TBL] [Abstract][Full Text] [Related]
5. Expression of HLA-DR on T lymphocytes following renal transplantation, and association with graft-rejection episodes and cytomegalovirus infection. van Es A; Baldwin WM; Oljans PJ; Tanke HJ; Ploem JS; van Es LA Transplantation; 1984 Jan; 37(1):65-9. PubMed ID: 6320508 [TBL] [Abstract][Full Text] [Related]
6. Lack of correlation between the induction of donor class I and class II major histocompatibility complex antigens and graft rejection. Wood KJ; Hopley A; Dallman MJ; Morris PJ Transplantation; 1988 Apr; 45(4):759-67. PubMed ID: 3282359 [TBL] [Abstract][Full Text] [Related]
7. The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients. Sagedal S; Nordal KP; Hartmann A; Sund S; Scott H; Degré M; Foss A; Leivestad T; Osnes K; Fauchald P; Rollag H Am J Transplant; 2002 Oct; 2(9):850-6. PubMed ID: 12392291 [TBL] [Abstract][Full Text] [Related]
8. Role of cytomegalovirus infection in allograft rejection: a review of possible mechanisms. Borchers AT; Perez R; Kaysen G; Ansari AA; Gershwin ME Transpl Immunol; 1999 Jun; 7(2):75-82. PubMed ID: 10544437 [TBL] [Abstract][Full Text] [Related]
9. Treatment with anti-MHC-class-II antibody postpones kidney allograft rejection in primates but increases the risk of CMV activation. Jonker M; Ringers J; Kuhn EM; 't Hart B; Foulkes R Am J Transplant; 2004 Nov; 4(11):1756-61. PubMed ID: 15476473 [TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus infection enhances the neointima formation in rat aortic allografts: effect of major histocompatibility complex class I and class II antigen differences. Li F; Yin M; Van Dam JG; Grauls G; Rozing J; Bruggeman CA Transplantation; 1998 May; 65(10):1298-304. PubMed ID: 9625009 [TBL] [Abstract][Full Text] [Related]
12. The association of the induction of vascular cell adhesion molecule-1 with cytomegalovirus antigenemia in human heart allografts. Koskinen PK Transplantation; 1993 Nov; 56(5):1103-8. PubMed ID: 7504341 [TBL] [Abstract][Full Text] [Related]
13. CMV-induced class II antigen expression in various rat organs. Ustinov J; Loginov R; Bruggeman C; Suni J; Häyry P; Lautenschlager I Transpl Int; 1994 Jul; 7(4):302-8. PubMed ID: 7916933 [TBL] [Abstract][Full Text] [Related]
14. Coronary arteriosclerosis after T-cell-mediated injury in transplanted mouse hearts: role of interferon-gamma. Nagano H; Libby P; Taylor MK; Hasegawa S; Stinn JL; Becker G; Tilney NL; Mitchell RN Am J Pathol; 1998 May; 152(5):1187-97. PubMed ID: 9588888 [TBL] [Abstract][Full Text] [Related]
15. Differentiation of cytomegalovirus infection from acute rejection using renal allograft fine needle aspirates. Nast CC; Wilkinson A; Rosenthal JT; Barba L; Bretan PN; Beaumont P; Danovitch GM J Am Soc Nephrol; 1991 May; 1(11):1204-11. PubMed ID: 1657240 [TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus infection in renal transplant recipients: one center's experience. Bal Z; Uyar ME; Tutal E; Erdogan E; Colak T; Sezer S; Haberal M Transplant Proc; 2013; 45(10):3520-3. PubMed ID: 24314948 [TBL] [Abstract][Full Text] [Related]
17. The impact of cytomegalovirus infections and acute rejection episodes on the development of vascular changes in 6-month protocol biopsy specimens of cadaveric kidney allograft recipients. Helantera I; Koskinen P; Tornroth T; Loginov R; Gronhagen-Riska C; Lautenschlager I Transplantation; 2003 Jun; 75(11):1858-64. PubMed ID: 12811246 [TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus infection of the liver transplant: virological, histological, immunological, and clinical observations. Lautenschlager I; Halme L; Höckerstedt K; Krogerus L; Taskinen E Transpl Infect Dis; 2006 Mar; 8(1):21-30. PubMed ID: 16623817 [TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus-induced regulation of major histocompatibility complex class I antigen expression in human aortic smooth muscle cells. Hosenpud JD; Chou SW; Wagner CR Transplantation; 1991 Nov; 52(5):896-903. PubMed ID: 1658993 [TBL] [Abstract][Full Text] [Related]
20. IgM and IgG alloantibody responses to MHC class I and II following rat renal allograft rejection. Effects of transplantectomy and posttransplantation blood transfusion. Wray DW; Baldwin WM; Sanfilippo F Transplantation; 1992 Jan; 53(1):167-74. PubMed ID: 1370736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]